Can you drink alcohol while taking peptides?
What each compound’s label or studies say about alcohol, or the concern that follows from how it works.
- Compounds
- 94
- From labels
- 10
- From human studies
- 6
- Precautions
- 32
- No study or data
- 42
Approved drugs come first in each group. This summarizes each compound’s own page; it isn’t medical advice, and a doctor or pharmacist can answer for a specific person.
From a product label 10
- DSIPApproved drug
- LabelDeltaran is registered in Russia as add-on treatment for alcohol withdrawal and craving, and its label lists no drug incompatibilities. No study has tested drinking while using DSIP.
- EnlicitideApproved drug
- LabelThe label doesn’t address alcohol. It is taken fasting with only water, black coffee or plain tea, then nothing else to drink for 30 minutes.
- GlutathioneApproved drug
- LabelThe Italian label says studies showed a protective role in poisonings, including from alcohol, but gives no advice on drinking. No study has tested wellness shots with drinking.
- LeuprolideApproved drug
- LabelThe women’s labels list heavy drinking (over 3 units a day) as a major risk factor for bone loss that may add to leuprolide’s own effect. No other alcohol advice is given.
- LixisenatideApproved drug
- LabelThe labels don’t address lixisenatide and alcohol, but Soliqua’s lists alcohol among things that can raise or lower its blood-sugar effect. Heavy drinking can also cause pancreatitis.
- PramlintideApproved drug
- LabelThe Medication Guide says drinking alcohol may raise the chance of severe low blood sugar while using pramlintide with insulin.
- PT-141Approved drug
- LabelPer the label, in 24 adults given a high nasal dose, alcohol didn’t change drug levels. Flushing matched bremelanotide alone, headache matched alcohol alone, and blood pressure drops on standing matched alcohol alone.
- SelankApproved drug
- LabelThe Russian label says no interaction with alcohol has been found. In rats it eased alcohol-withdrawal anxiety without changing how much they drank; no human study has tested drinking with Selank.
- ThymalinApproved drug
- LabelThe Russian label advises against drinking alcohol while using it.
- TriptorelinApproved drug
- LabelThe UK label lists chronic heavy drinking as an osteoporosis risk factor that likely makes the drug’s bone loss more harmful, and urges particular caution. US labels don’t mention alcohol.
From human studies 6
- DulaglutideApproved drug
- TrialThe label doesn’t address alcohol. In a 12-week smoking-cessation trial, participants on dulaglutide drank 29% less than those on placebo. Heavy drinking itself raises pancreatitis risk.
- ExenatideApproved drug
- TrialThe label doesn’t address alcohol. In a 26-week trial of 127 people with alcohol use disorder, weekly exenatide didn’t reduce heavy drinking days overall. Heavy drinking itself raises pancreatitis risk.
- OxytocinApproved drug
- TrialStudied for alcohol use disorder: a 12-week trial of 100 adults found no drop in heavy drinking vs placebo, and a 2026 review of 6 trials found no consistent benefit. It was well tolerated.
- TeriparatideApproved drug
- TrialThe labels don’t address alcohol. In the men’s trial, bone density gains were similar regardless of alcohol intake.
- LarazotideHuman studies
- TrialNo data on combining them. A 2012 trial limited drinking (under 3 fluid ounces in the 48 hours before gut-permeability tests), as alcohol can affect gut permeability.
- MK-677Human studies
- TrialNo study has tested the combination. In one trial, liver enzymes tripled in a man who drank against the protocol; ghrelin, which MK-677 mimics, raised alcohol craving in heavy drinkers.
A precaution, not studied 32
- AbaloparatideApproved drug
- PrecautionThe labels don’t address alcohol. Abaloparatide can cause dizziness and blood pressure drops after injections, which alcohol could add to.
- DasiglucagonApproved drug
- PrecautionThe label doesn’t mention alcohol. Heavy drinking without food can drain the liver’s sugar stores, and the label says it may not work when those stores are low, as in starvation.
- DesmopressinApproved drug
- PrecautionThe labels don’t mention alcohol, but they limit fluids around each dose. Drinking large volumes of any liquid, beer included, while desmopressin is working raises the risk of dangerously low sodium.
- EcnoglutideApproved drug
- PrecautionNo data. Heavy drinking can cause pancreatitis and, with insulin or sulfonylureas, low blood sugar, both listed risks of approved GLP-1 drugs.
- GHRP-2Approved drug
- PrecautionNo study has tested it with alcohol. In 45 heavy drinkers, IV ghrelin, the hunger hormone whose receptor GHRP-2 activates, increased alcohol craving; whether GHRP-2 does is unknown.
- GlucagonApproved drug
- PrecautionThe labels don’t mention alcohol. Heavy drinking without food can drain the liver’s sugar stores, and the labels say glucagon may not work when those stores are low, as in starvation.
- IcotrokinraApproved drug
- PrecautionThe labels don’t mention alcohol, and no study has tested the combination. Icotrokinra isn’t processed by liver enzymes, so a drug interaction with alcohol is unlikely.
- LinaclotideApproved drug
- PrecautionThe labels don’t mention alcohol. Heavy drinking adds to fluid loss, which could worsen the dehydration that severe diarrhea on linaclotide can cause.
- LiraglutideApproved drug
- PrecautionThe labels don’t address alcohol. Heavy drinking can cause pancreatitis and, with insulin or sulfonylureas, low blood sugar, both listed risks. A Swedish registry linked liraglutide to fewer alcohol-related hospital stays, unproven as cause.
- MazdutideApproved drug
- PrecautionNo human data yet: a 308-person trial of mazdutide for alcohol use disorder finished in May 2026, unpublished. Heavy drinking can itself cause pancreatitis (pancreas inflammation), a listed risk of related drugs.
- MecaserminApproved drug
- PrecautionThe labels don’t address alcohol. Alcohol can itself cause low blood sugar, mecasermin’s main risk, so the two could add up.
- Melanotan 1Approved drug
- PrecautionThe labels don’t address alcohol. Nausea, dizziness and sleepiness are listed side effects, and the EU label warns against driving when affected; alcohol could add to these.
- OctreotideApproved drug
- PrecautionThe labels don’t address alcohol. Octreotide can push blood sugar up or down and is linked to pancreatitis, and heavy drinking can do both.
- OrforglipronApproved drug
- PrecautionThe label doesn’t address alcohol. Heavy drinking can cause pancreatitis and, with insulin or sulfonylureas, low blood sugar, both listed risks. No study has tested orforglipron for drinking.
- PalopegteriparatideApproved drug
- PrecautionThe labels don’t address alcohol. Dizziness and blood pressure drops on standing are common early in treatment, and alcohol could add to them.
- PlecanatideApproved drug
- PrecautionThe label doesn’t mention alcohol. Heavy drinking adds to fluid loss, which could worsen dehydration if diarrhea is severe.
- SemaglutideApproved drug
- PrecautionThe labels don’t address alcohol. Heavy drinking can itself cause pancreatitis (pancreas inflammation) and, with insulin or sulfonylurea pills, low blood sugar, both listed risks of semaglutide.
- SetmelanotideApproved drug
- PrecautionThe label doesn’t address alcohol, and no interaction is known. Alcohol can worsen low mood, and depression is a label warning.
- Somatropin (HGH)Approved drug
- PrecautionThe labels don’t address alcohol, and no study has tested the combination. Growth hormone can raise blood sugar, and heavy drinking also disturbs blood sugar control.
- TeduglutideApproved drug
- PrecautionThe labels don’t address alcohol. Heavy drinking can add to dehydration and pancreatitis, both relevant risks in short bowel syndrome treated with teduglutide.
- TesamorelinApproved drug
- PrecautionThe label doesn’t address drinking, and no study has tested the combination. Heavy drinking can itself add liver fat and upset blood sugar, both things tesamorelin can affect.
- TirzepatideApproved drug
- PrecautionThe labels don’t address alcohol. Heavy drinking can itself cause pancreatitis and, with insulin or sulfonylureas, low blood sugar, both listed risks of tirzepatide. Small trials in alcohol use disorder are under way.
- VIPApproved drug
- PrecautionNo data. Neither Invicorp’s label nor the trials address alcohol. Both widen blood vessels, so flushing or lightheadedness could add up.
- ZiconotideApproved drug
- PrecautionThe labels don’t name alcohol, but they warn that other brain-depressant drugs add to ziconotide’s confusion and drowsiness, and alcohol has similar effects.
- GHRP-6Human studies
- PrecautionNo study has tested it with alcohol. In 45 heavy drinkers, IV ghrelin, the hunger hormone whose receptor GHRP-6 activates, increased alcohol craving; whether GHRP-6 does is unknown.
- HexarelinHuman studies
- PrecautionNo study has tested it with alcohol. In 45 heavy drinkers, IV ghrelin, the hunger hormone whose receptor hexarelin activates, increased alcohol craving; whether hexarelin does is unknown.
- IpamorelinHuman studies
- PrecautionNo data for ipamorelin. Ghrelin, which acts on the same receptor, increased alcohol craving in a 45-person lab study of heavy drinkers; whether ipamorelin does is unknown.
- Melanotan 2Human studies
- PrecautionNo melanotan II data. In a study of bremelanotide, its near-identical relative, alcohol didn’t change drug levels, and flushing and headache matched rates seen with either alone.
- SurvodutideHuman studies
- PrecautionNo human data; the liver trials excluded heavy drinkers. Heavy drinking can itself cause pancreatitis (pancreas inflammation), a listed risk of related GLP-1 drugs.
- IGF-1 DESPreclinical
- PrecautionNo data. Alcohol can itself cause low blood sugar, the main expected risk of IGF-1 compounds, so the two could add up.
- IGF-1 LR3Preclinical
- PrecautionNo data. Alcohol can itself cause low blood sugar, the main expected risk of IGF-1 compounds, so the two could add up.
- MOTS-cPreclinical
- PrecautionNo data. Alcohol can cause low blood sugar, especially without food, and MOTS-c lowered blood sugar in animals, so the effects could add up.
From animal studies 4
- CerebrolysinApproved drug
- AnimalNo human data; neither label mentions alcohol. In rats it lessened alcohol-induced memory problems (2019), an animal result that says nothing about safety in people.
- SemaxApproved drug
- AnimalNo human data, and neither Russian label mentions alcohol. In rats, Semax protected the stomach lining from alcohol damage (2000), an animal result that says nothing about drinking while using it.
- RetatrutideHuman studies
- AnimalNo human data. In rats, a single dose blunted how alcohol’s effects were sensed (2026), an animal result. Heavy drinking can itself cause pancreatitis, a listed risk of related drugs.
- BPC-157Preclinical
- AnimalNo human data. In mice, it lessened acute alcohol intoxication and withdrawal (2004), an animal result that says nothing about safety in people.
No study or report 42
- CalcitoninApproved drug
- No studyThe labels don’t mention alcohol, and no study has tested the combination.
- CetrorelixApproved drug
- No studyNo data; the labels don’t mention alcohol.
- CosyntropinApproved drug
- No studyThe labels don’t mention alcohol, and no study has tested the combination.
- GanirelixApproved drug
- No studyNo data; the labels don’t mention alcohol.
- GonadorelinApproved drug
- No studyNo data. No label or study addresses alcohol with gonadorelin.
- hCGApproved drug
- No studyNo data: no label or study addresses alcohol with hCG, and no interaction is known.
- L-CarnitineApproved drug
- No studyThe labels don’t mention alcohol, and no study has tested drinking alongside carnitine injections. A small pilot of oral L-carnitine for alcohol craving finished in 2025, unpublished.
- MacimorelinApproved drug
- No studyThe labels don’t address alcohol. The test is done after fasting at least 8 hours, and no study has looked at alcohol’s effect on the result.
- SS-31Approved drug
- No studyNo data; the label doesn’t mention drinking alcohol. The benzyl alcohol listed in the vial is a preservative, not the alcohol in drinks.
- Thymosin Alpha-1Approved drug
- No studyNo data; neither label mentions alcohol.
- AOD9604Human studies
- No studyNo data. No study has looked at alcohol with it.
- ARA-290Human studies
- No studyNo data: no trial has looked at alcohol alongside it, and the trial reports don’t address drinking.
- ArgirelineHuman studies
- No studyNo data: no study has looked at alcohol and Argireline together.
- CagrilintideHuman studies
- No studyNo human data yet. A 270-person trial of cagrilintide, alone or with semaglutide, in alcohol-related liver disease finished in January 2026, with no results published.
- CJC-1295 with DACHuman studies
- No studyNo data. No study has looked at alcohol with CJC-1295.
- DihexaHuman studies
- No studyNo data; no study has looked at dihexa and alcohol.
- GHK-CuHuman studies
- No studyNo data: no study has looked at alcohol and GHK-Cu together.
- Kisspeptin-10Human studies
- No studyNo data. No study has looked at alcohol with kisspeptin-10.
- LL-37Human studies
- No studyNo data: no study has looked at alcohol and LL-37 together.
- MatrixylHuman studies
- No studyNo data: no study has looked at alcohol and Matrixyl together.
- NAD+Human studies
- No studyNo human data on drinking alongside NAD+ shots. Clinics market IV NAD+ for alcohol withdrawal, but no controlled study has tested it.
- SermorelinHuman studies
- No studyNo data: neither former label mentions alcohol, and no study has tested the combination.
- SNAP-8Human studies
- No studyNo data: no study has looked at alcohol and SNAP-8 together.
- TesofensineHuman studies
- No studyNo data; its obesity trials excluded people who drank heavily (over 21 units a week for men, 14 for women).
- Thymosin Beta-4Human studies
- No studyNo data: no study has looked at alcohol and thymosin beta-4 together.
- 5-Amino-1MQPreclinical
- No studyNo data.
- AdamaxPreclinical
- No studyNo data; Adamax has never been studied, alone or with alcohol.
- AHK-CuPreclinical
- No studyNo data: no study has looked at alcohol and AHK-Cu together.
- CartalaxPreclinical
- No studyNo data. No study has looked at cartalax and alcohol together.
- CJC-1295 (no DAC)Preclinical
- No studyNo data. No study has looked at alcohol with any form of CJC-1295.
- EpithalonPreclinical
- No studyNo data. No study has looked at Epithalon and alcohol together.
- Follistatin-344Preclinical
- No studyNo data: no study has looked at alcohol together with follistatin.
- FOXO4-DRIPreclinical
- No studyNo data. No study has looked at FOXO4-DRI and alcohol together.
- HGH Fragment 176-191Preclinical
- No studyNo data.
- HumaninPreclinical
- No studyNo data. No study has looked at humanin and alcohol together.
- KPVPreclinical
- No studyNo data: no study has looked at alcohol and KPV together.
- MGFPreclinical
- No studyNo data: no study has looked at alcohol and MGF together.
- PE-22-28Preclinical
- No studyNo data; no study has looked at PE-22-28 and alcohol.
- PEG-MGFPreclinical
- No studyNo data: no study has looked at alcohol and PEG-MGF together.
- PinealonPreclinical
- No studyNo data. No study has looked at pinealon and alcohol together.
- SLU-PP-332Preclinical
- No studyNo data.
- TB-500Preclinical
- No studyNo data: no study has looked at alcohol and TB-500 together.
Sources
Each answer comes from the compound’s own page, where its sources are listed.